Development of SGLT2 inhibitors as antidiabetic drugs based on new rationale

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

本文言語	英語
ページ（範囲）	33-34
ページ数	2
ジャーナル	Japanese Journal of Clinical Pharmacology and Therapeutics
巻	45
号	1
DOI	https://doi.org/10.3999/jscpt.45.33
出版ステータス	出版済み - 2014
外部発表	はい

All Science Journal Classification (ASJC) codes

@article{44cdac3c2ba04875ac47f6da83423443,

title = "Development of SGLT2 inhibitors as antidiabetic drugs based on new rationale",

author = "Yoshikatsu Kanai",

year = "2014",

doi = "10.3999/jscpt.45.33",

language = "English",

volume = "45",

pages = "33--34",

journal = "Japanese Journal of Clinical Pharmacology and Therapeutics",

issn = "0388-1601",

publisher = "Japanese Society of Clinical Pharmacology and Therapeutics",

number = "1",

}

TY - JOUR

T1 - Development of SGLT2 inhibitors as antidiabetic drugs based on new rationale

AU - Kanai, Yoshikatsu

PY - 2014

Y1 - 2014

UR - https://www.scopus.com/pages/publications/84894410947

UR - https://www.scopus.com/pages/publications/84894410947#tab=citedBy

U2 - 10.3999/jscpt.45.33

DO - 10.3999/jscpt.45.33

M3 - Article

AN - SCOPUS:84894410947

SN - 0388-1601

VL - 45

SP - 33

EP - 34

JO - Japanese Journal of Clinical Pharmacology and Therapeutics

JF - Japanese Journal of Clinical Pharmacology and Therapeutics

IS - 1

ER -